References
- Hume H A, Preiksaitis J B. Transfusion associated graft-versus-host disease, cytomegalovirus infection and HLA alloimmunization in neonatal and pediatric patients. Transfus Sci 1999; 21: 73–95
- Schroeder M L. Transfusion-associated graft-versus-host disease. Br J Haematol 2002; 117: 275–287
- Greenbaum B H. Transfusion-associated graft-versus-host disease: historical perspectives, incidence, and current use of irradiated blood products. J Clin Oncol 1991; 9: 1889–1902
- Mathe G, Bernard J, Schwarzenberg L. [New trials with homologous bone marrow grafts after total irradiation in children with acute leukemia in remission. The problem of the secondary syndrome in man]. [Article in French]. Rev Hematol (Paris) 1960; 15: 115–161
- Wang L, Tadokoro K, Tokunaga K, Uchida S, Moriyama S, Bannai M, Mitsunaga S, Takai K, Juji T. Restricted use of T-cell receptor V beta genes in post-transfusion graft-versus-host disease. Transfusion 1997; 37: 1184–1191
- Ohto H, Anderson K C. Post-transfusion graft-versus-host disease in Japanese newborns. Transfusion 1996; 36: 117–123
- Özkan H, Ören H, Duman N, Özkan Ş, Sarioğlu S, Anal Ö, Simsek A, Sagol O, Irken G. Transfusion-associated graft-versus-host disease following exchange transfusion in a newborn. Eur J Pediatr 1999; 158: 343
- Jindal B, Narang A, Das R. Post-transfusion graft versus host disease—an under recognized entity. Indian Pediatr 2001; 38: 179–183
- Gupta A, Bansal D, Dass R, Das A. Transfusion associated graft versus host disease. Indian Pediatr 2004; 41: 1260–1264
- Sohi I, Jacob S. Transfusion associated GVHD. Indian J Pediatr 2005; 72: 533–535